O, N., GL, A., RT, C., SY, J., HR, H., S, K., & PE, L. (2025). MGMT epimutations and risk of incident cancer of the colon, glioblastoma multiforme, and diffuse large B cell lymphomas. Clinical epigenetics, 17(1), 28. https://doi.org/10.1186/s13148-025-01835-x
Chicago Style (17th ed.) CitationO, Nikolaienko, Anderson GL, Chlebowski RT, Jung SY, Harris HR, Knappskog S, and Lønning PE. "MGMT Epimutations and Risk of Incident Cancer of the Colon, Glioblastoma Multiforme, and Diffuse Large B Cell Lymphomas." Clinical Epigenetics 17, no. 1 (2025): 28. https://doi.org/10.1186/s13148-025-01835-x.
MLA (9th ed.) CitationO, Nikolaienko, et al. "MGMT Epimutations and Risk of Incident Cancer of the Colon, Glioblastoma Multiforme, and Diffuse Large B Cell Lymphomas." Clinical Epigenetics, vol. 17, no. 1, 2025, p. 28, https://doi.org/10.1186/s13148-025-01835-x.